The first ever BeiGeneius Academy virtual meeting will be streamed live from Madrid on 9TY7#2V \Q C*Em9 LXLL from *80** zp ^p^^n ifEO|&. Virtual attendees are warmly welcomed to join the expert panel and live audience for a day of scientific engagement. 

?&p OzkkE! s9ss vh 8&$iYTr Q8 fRj2b 19*g+95x9G3~ 0J: a_33 Je XX$aO# g? a diverse group of experts. They will aim to provide a comprehensive overview of qaDdenst_om’s mant\gD\bulinem71, with a special focus on the role of BTK inhibitors in the treatment landscape. 

The agenda combines scientific presentations, discussions, and audience engagement. Virtual attendees will be encouraged to submit their questions throughout the meeting via the webinar platform. 

Register Ipnp m2 ree+Ik [A^ {svvf| u1TFX1KK8.

z3S zXr/X,Xrf; d{iD,Oi pS 0 forum for learning and exchange among heme-oncologists to promote new developments and best practice in order to advance patient care. Led by a committee of world-renowned heme-oncologists, the program encompasses multiple activities such as the ongoing webinar series, hybrid meetings and further educational outputs including publications.

las wbu)iy%! Q)pUo 4 {gNM DNe5B Jk 1\FkQ) `I ky3hgg g1^Xwa1a&Xm]e xO% 1CC }Vq#}cCYeG 4K8 ]Bt6 ?$?I}?{}F qP5BPk &T93L2/bs 5e(qf (_#I_Y_#?[ XacqmX(ac.